Seco-LSD
Seco-LSD is an structural analog, analogue of LSD with one or more covalent bond, bonds removed and may refer to: * 3,5-Seco-LSD (also known as DEIMDHPCA) * 8,10-Seco-LSD (also known as NDTDI) * 10,11-Seco-LSD Additional seco-LSD compounds with more bonds removed include DEMPDHPCA, N-DEAOP-NMT, ''N''-DEAOP-NMT, and N-DEAOP-NMPEA, ''N''-DEAOP-NMPEA. See also

* Secoergoline * Partial ergoline * Secosteroid {{Chemistry index Partial ergolines ...
[...More Info...]       [...Related Items...]     OR:     [Wikipedia]   [Google]   [Baidu]  

10,11-Seco-LSD
10,11-Seco-LSD is a partial lysergamide and cyclized tryptamine related to lysergic acid diethylamide (LSD). It is the seco structural analog, analogue of LSD in which the covalent bond, bond between the 10 and 11 positions of the ergoline ring system (chemistry), ring system has been broken. 10,11-Seco-LSD was described in a patent by David E. Olson and colleagues at Delix Therapeutics in 2021. Its pharmacology was not described. See also * Partial lysergamide * Seco-LSD * Secoergoline * NDTDI (8,10-seco-LSD) * DEIMDHPCA (3,5-seco-LSD) References

Carboxamides Diethylamino compounds N,N-Dialkyltryptamines Partial ergolines Tetrahydropyridines {{Hallucinogen-stub ...
[...More Info...]       [...Related Items...]     OR:     [Wikipedia]   [Google]   [Baidu]